6M0F image
Entry Detail
PDB ID:
6M0F
Title:
X-ray structure of Drosophila dopamine transporter with subsiteB mutations (D121G/S426M) in substrate-free form
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2020-02-21
Release Date:
2021-02-17
Method Details:
Experimental Method:
Resolution:
3.30 Å
R-Value Free:
0.27
R-Value Work:
0.24
R-Value Observed:
0.24
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Sodium-dependent dopamine transporter
Mutations:Deletion of N-terminal 1-24 and 162-202, V74A, D121G, L415A, S426M
Chain IDs:A
Chain Length:534
Number of Molecules:1
Biological Source:Drosophila melanogaster
Polymer Type:polypeptide(L)
Description:Antibody fragment (9D5) heavy chain
Chain IDs:C (auth: H)
Chain Length:219
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:Antibody fragment (9D5) Light chain
Chain IDs:B (auth: L)
Chain Length:214
Number of Molecules:1
Biological Source:Mus musculus
Primary Citation
Structural basis of norepinephrine recognition and transport inhibition in neurotransmitter transporters.
Nat Commun 12 2199 2199 (2021)
PMID: 33850134 DOI: 10.1038/s41467-021-22385-9

Abstact

Norepinephrine is a biogenic amine neurotransmitter that has widespread effects on alertness, arousal and pain sensation. Consequently, blockers of norepinephrine uptake have served as vital tools to treat depression and chronic pain. Here, we employ the Drosophila melanogaster dopamine transporter as a surrogate for the norepinephrine transporter and determine X-ray structures of the transporter in its substrate-free and norepinephrine-bound forms. We also report structures of the transporter in complex with inhibitors of chronic pain including duloxetine, milnacipran and a synthetic opioid, tramadol. When compared to dopamine, we observe that norepinephrine binds in a different pose, in the vicinity of subsite C within the primary binding site. Our experiments reveal that this region is the binding site for chronic pain inhibitors and a determinant for norepinephrine-specific reuptake inhibition, thereby providing a paradigm for the design of specific inhibitors for catecholamine neurotransmitter transporters.

Legend

Protein

Chemical

Disease

Primary Citation of related structures